Learn More
Medchemexpress LLC 1,3-dihydro-5,6-dimethoxy-3-[(4-hydroxyphenyl)methylene]-1H-indol-2-one | 269730-03-2 | MFCD03852474 | 99.3% | 297.31 g/mol | C17H15NO4 | 25 MG

Supplier: Medchemexpress LLC HY10124625MG
RPI-1 is a research-grade 2-indolinone inhibitor of RET tyrosine kinase that inhibits RET phosphorylation and downstream signaling (PLCγ, ERKs, AKT) and shows antiproliferative activity in RET-driven tumor cell models. It is supplied as a solid powder for laboratory research use only.
- Mechanism: inhibits RET tyrosine kinase and downstream signaling.
- Purity: 99.29% (manufacturer reported).
- Molecular formula: C17H15NO4; molecular weight: 297.31 g/mol.
- Physical form: solid powder suitable for solution preparation.
- Storage: powder -20°C for long-term, 4°C for short-term; in solvent store at -80°C when possible.
- Intended use: for research use only, not for human or clinical use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.